Molecular Characterization of HIV Type 1 Among HIV-Infected Respondents in a Cohort Being Prepared for HIV Phase III Vaccine Clinical Trials, Western Kenya

AIDS Research and Human Retroviruses - United States
doi 10.1089/aid.2010.0061
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Pediatric HIV Type 1 Vaccine Trial Acceptability Among Mothers in Kenya

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2006English

Volunteer Motivators for Participating in HIV Vaccine Clinical Trials in Nairobi, Kenya

PLoS ONE
Multidisciplinary
2017English

Sieve Analysis in HIV-1 Vaccine Efficacy Trials

Current Opinion in HIV and AIDS
VirologyOncologyInfectious DiseasesImmunologyHematology
2013English

Knowing a Sexual Partner Is HIV-1-Uninfected Is Associated With Higher Condom Use Among HIV-1-Infected Adults in Kenya

Sexually Transmitted Diseases
Public HealthMicrobiologyEnvironmentalDermatologyInfectious DiseasesOccupational Health
2011English

Rectal Microbiota Among HIV-uninfected, Untreated HIV, and Treated HIV-infected in Nigeria

AIDS
Infectious DiseasesAllergyImmunology
2017English

Performance of Clinical Algorithms for HIV-1 Diagnosis and Antiretroviral Initiation Among HIV-1-Exposed Children Aged Less Than 18 Months in Kenya

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2009English

A Proposal to Use Iterative, Small Clinical Trials to Optimize Therapeutic HIV Vaccine Immunogens to Launch Therapeutic HIV Vaccine Development

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2015English

HIV and cART-Associated Dyslipidemia Among HIV-Infected Children

Journal of Clinical Medicine
2019English

Novel Vaccine Vectors for HIV-1

Nature Reviews Microbiology
Infectious DiseasesImmunologyMicrobiologyMicrobiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy